As of 2024-07-27, the EV/EBITDA ratio of Alexion Pharmaceuticals Inc (ALXN) is
12.38.
EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Alexion's latest enterprise value
is 39,557.69 mil USD. Alexion's TTM EBITDA according to its financial statements is
3,196.40 mil USD. Dividing these 2
quantities gives us the above Alexion EV/EBITDA ratio.
|
Range |
Selected |
| Trailing P/E multiples |
18.2x - 28.3x |
27.5x |
| Forward P/E multiples |
26.3x - 40.0x |
29.3x |
| Fair Price |
112.45 - 412.12 |
262.61 |
| Upside |
-38.4% - 125.8% |
43.9% |